PCYC Financial Facts

Loss from operations: -46.29M
Total revenues: 23.7M
See Full Income Statement

See Full Balance Sheet

Pharmacyclics, Inc. (PCYC) Earnings

  |   Expand Research on PCYC
Next EPS Date 5/6/14 *Est. EPS Growth Rate +531.8% *Last Qtr.
Average EPS % Beat Rate +169.8% Revenue Growth Rate +5,785.7% *Last Qtr.
Average % Move 1-Wk after EPS +0.0% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
9/12/11 Q411 -$0.15-$0.14 -$0.01$1.39M$2.67M N/A +718.5% Details
11/7/11 Q311 -$0.18-$0.16 -$0.02$37K$2.41M N/A +614.6% Details
2/9/12 Q212 $0.82-$0.18 +$1.00$77.9M$2.64M N/A +400.5% Details
5/10/12 Q112 -$0.14-$0.23 +$0.09$1.93M$3.14M N/A +236.1% Details
9/5/12 Q412 -$0.22-$0.27 +$0.05$2.1M$3.49M = +29% Details
11/5/12 Q113 $1.14$0.75 +$0.39$102.7M$87.64M = +56.9% Details
2/14/13 Q213 $0.62$0.29 +$0.33$57.96M$45.74M = +11.4% Details
7/31/13 Q313 $0.26-$0.07 +$0.33$54.7M$52M = -17.6% Details